The Impact of Optical Coherence Tomography on the Endovascular Treatment Planning of Femoropopliteal Disease
The Impact of Optical Coherence Tomography on the Decision-making Process of Endovascular Treatment of Femoropopliteal Disease
Sponsor: Abbott
This observational or N/A phase trial investigates Femoropopliteal Stenosis and is currently ongoing. Abbott leads this study, which shows 9 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Change History
9 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting
-
Sep 2025 — Feb 2026 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
May 2025 — Sep 2025 [monthly]
Recruiting
-
Dec 2024 — May 2025 [monthly]
Recruiting
-
Sep 2024 — Dec 2024 [monthly]
Recruiting
▶ Show 4 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Sep 2023 — Jul 2024 [monthly]
Recruiting
-
Jun 2022 — Sep 2023 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Oct 2021 — Jun 2022 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott
- Rijnstate Hospital
- University of Twente
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Arnhem, Netherlands